- Home
- CDXS vs RMR Comparison
CDXS vs RMR Comparison
Compare CDXS & RMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- RMR
- Stock Information
- Founded
- CDXS 2002
- RMR 1986
- Country
- CDXS United States
- RMR United States
- Employees
- CDXS N/A
- RMR N/A
- Industry
- CDXS Major Chemicals
- RMR Professional Services
- Sector
- CDXS Industrials
- RMR Consumer Discretionary
- Exchange
- CDXS Nasdaq
- RMR Nasdaq
- Market Cap
- CDXS 254.3M
- RMR 290.8M
- IPO Year
- CDXS 2010
- RMR N/A
- Fundamental
- Price
- CDXS $2.44
- RMR $16.98
- Analyst Decision
- CDXS Buy
- RMR
- Analyst Count
- CDXS 2
- RMR 0
- Target Price
- CDXS $11.00
- RMR N/A
- AVG Volume (30 Days)
- CDXS 1.1M
- RMR 63.9K
- Earning Date
- CDXS 10-30-2025
- RMR 11-10-2025
- Dividend Yield
- CDXS N/A
- RMR 10.64%
- EPS Growth
- CDXS N/A
- RMR N/A
- EPS
- CDXS N/A
- RMR 1.12
- Revenue
- CDXS $57,164,000.00
- RMR $194,993,000.00
- Revenue This Year
- CDXS $12.88
- RMR $323.25
- Revenue Next Year
- CDXS $21.64
- RMR $1.07
- P/E Ratio
- CDXS N/A
- RMR $15.06
- Revenue Growth
- CDXS N/A
- RMR 1.73
- 52 Week Low
- CDXS $1.90
- RMR $13.48
- 52 Week High
- CDXS $6.08
- RMR $26.06
- Technical
- Relative Strength Index (RSI)
- CDXS 37.30
- RMR 54.17
- Support Level
- CDXS $2.37
- RMR $16.64
- Resistance Level
- CDXS $2.54
- RMR $17.10
- Average True Range (ATR)
- CDXS 0.12
- RMR 0.28
- MACD
- CDXS -0.01
- RMR 0.03
- Stochastic Oscillator
- CDXS 30.00
- RMR 74.29
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About RMR The RMR Group Inc.
The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.